Corbus Pharmaceuticals
CRBP
CRBP
82 hedge funds and large institutions have $114M invested in Corbus Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $144M → $114M (-$29.9M)
38% less call options, than puts
Call options by funds: $510K | Put options by funds: $825K
Holders
82
Holding in Top 10
1
Calls
$510K
Puts
$825K
Top Buyers
| 1 | +$2.53M | |
| 2 | +$1.59M | |
| 3 | +$1.1M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$908K |
| 5 |
Renaissance Technologies
New York
|
+$842K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$1.26M | |
| 3 | -$510K | |
| 4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$220K |
| 5 |
Squarepoint
New York
|
-$147K |